Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 549-555

  Reed, Jon A ^a   Finnerty, Bridget ^b   Albino, Anthony P ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE; NERVE GROWTH FACTOR RECEPTOR; NEUROMODULIN;

ARTICLE; CANCER INVASION; CARCINOMA IN SITU; CELL DIFFERENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; PRIORITY JOURNAL; SCHWANN CELL;

EID: 0032801318     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65150-4     Document Type: Article

References (55)

1. Albino AP, Reed JA, McNutt NS: Molecular biology of cutaneous malignant melanoma. Cancer. Principles and Practice of Oncology. Edited by VT DeVita Jr, 3 Hellman, and SA Rosenberg. New York, Lippincott-Raven, 1997, pp 1935-1946
2. Quevedo WC Jr, Szabo G, Virks J, Sinesi J: Melanocyte populations in UV-irradiated human skin. J Invest Dermatol 1965, 45:295-298
3. Mishima Y, Tanay A: The effect of α-methyldopa and ultraviolet irradiation on melanogenesis. Dermatologica 1968, 136:105-114
4. Rosdahl IK: Melanocyte mitosis in UVB-irradiated mouse skin. Acta Dermatol Venereol 1978, 58:217-221
5. Lund HZ, Stobbe GD: The natural history of the pigmented nevus. Factors of age and anatomic location. Am J Pathol 1949, 25:1117-1147
6. Imber MJ, Mihm MC Jr: Benign melanocytic tumors. Pathology of the Skin. Edited by Farmer ER, Hood AF. Norwalk, CT, Appleton and Lange, 1990, pp 663-683
7. Goovaerts G, Buyssens N: Nevus cell maturation or atrophy. Am J Dermatopathol 1988, 10:20-27
8. Yang P, Hirose T, Hasegawa T, Seki K, Nakanishi H, Hizawa K: Ultrastructural heterogeneity of acquired intradermal melanocytic nevus cells. Ultrastruct Pathol 1996, 20:255-261
9. Brocker EB, Magiera H, Herlyn M: Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. J Invest Dermatol 1991, 96:662-665
10. Prieto VG, McNutt NS, Lugo J, Reed JA: The intermediate filament peripherin is expressed in cutaneous melanocytic lesions. J Cutan Pathol 1997, 24:145-150
11. Prieto VG, McNutt NS, Lugo J, Reed JA: Differential expression of the intermediate filament peripherin in cutaneous neural lesions and neurotized melanocytic nevi. Am J Surg Pathol 1997, 21:1450-1454
12. Gray MH, Smoller BR, McNutt NS, Hsu A: Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms. Am J Dermatopathol 1990, 12:234-241
13. Argenyi ZB, Rodgers J, Wick M: Expression of nerve growth factor and epidermal growth factor receptors in neural nevi with nevic corpuscles. Am J Dermatopathol 1996, 18:460-464
14. Aso M, Hashimoto K, Eto H, Fukaya T, Ishihara M, Shimao S, Shimizu Y: Expression of Schwann cell characteristics in pigmented nevus. Cancer 1988, 63:938-943
15. Le Douarin NM, Ziller C: Plasticity in neural crest cell differentiation. Curr Opin Cell Biol 1993, 5:1036-1043
16. Murphy M, Reid K, Dutto R, Brooker G, Bartlett PF: Neural stem cells. J Invest Dermatol Symp Proc 1997, 2:8-13
17. Carbonell AL, Boya J, Garcia-Maurino JE: Presence of melanin in normal human Schwann cells. Histol Histopathol 1992, 7:329-332
18. Khare VK, Albino AP, Reed JA: The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions. J Cutan Pathol 1998, 25:2-10
19. Lammerding-Koppel M, Noda S, Blum A, Schaumburg-Lever G, Rassner G, Drews U: Immunohistochemical localization of muscarinic acetylcholine receptors in primary and metastatic malignant melanomas. J Cutan Pathol 1997, 24:137-144
20. Dhillon AP, Rode J, Leathern A: Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma. Histopathology 1982, 6:81-92
21. Van Paesschen M-A, Goovaerts G, Buyssens N: A study of the so-called neurotization of nevi. Am J Dermatopathol 1990, 12:242-248
22. Si Z, Mersey P: Expression of the neuroglandular antigen and analogues in melanoma, CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer 1993, 54:37-43
23. Zorick TS, Lemke G: Schwann cell differentiation. Curr Opin Cell Biol 1996, 8:870-876
24. Mirsky R, Jessen KR: Schwann cell development, differentiation and myelination. Curr Opin Neurobiol 1996, 6:89-96
25. Ross AH, Grob P, Bothwell M, Elder DE, Ernst CS, Marano N, Ghrist CC, Herlyn M, Atkinson B, Koprowski H: Characterization of nerve growth factor receptor in neural crest tumors using monoclonal anti-bodies, Proc Natl Acad Sci USA 1984, 81:6681-6685
26. Schol DJ, Mooi WJ, van der Gugten AA, Wagenaar SSc, Hilgers J: Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron-supporting normal tissues. Int J Cancer Suppl 2 1988, 2:34-40
27. Meiri KF, Bickerstaff LE, Schwob JE: Monoclonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo. J Cell Biol 1991, 112:991-1005
28. Beckstead JH: Improved antigen retrieval in formalin-fixed paraffin-embedded tissue. Appl Immunohistochem 1994, 2:274-281
29. Reed JA, Manahan LJ, Park C-S, Brigati DJ: Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992, 13:434-443
30. Chao MV, Hempstead BL: p75 and trk: a two-receptor system. Trends Neurosci 1995, 18:321-326
31. Kaplan DR, Miller FD: Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 1997, 9:213-221
32. Barbacid M: Structural and functional properties of the trk family of neurotrophin receptors. Ann NY Acad Sci 1995, 766:442-458
33. Rettig WL, Thomson TM, Spengler BA, Biedler JL, Old LJ: Assignment of human nerve growth factor receptor gene to chromosome 17 and regulation of receptor expression in somatic cell hybrids. Somat Cell Mol Genet 1986, 12:441-447
34. Thompson SJ, Schatteman GC, Gown AM, Bothwell MA: A monoclonal antibody against nerve growth factor receptor, lmmunohisto-chemical analysis of normal and neoplastic human tissue. Am J Clin Pathol 1989, 92:415-423
35. Papandreou C, Bogenrieder T, Loganzo F, Chao MV, Nanus DM, Albino AP Mutation and expression of the low affinity neurotrophin receptor in human malignant melanoma. Melanoma Res 1996, 6:373-378
36. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA: Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994, 265:1596-1599
37. Marchetti D, Menter D, Jin L, Nicolson GL: Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer 1993, 55:692-699
38. Menter DG, Herrmann JL, Nicolson GL: The role of trophic factors and autocrine/paracrine growth factors in brain metastasis. Clin Exp Metastasis 1995, 13:67-88
39. Iwamoto S, Odland PB, Piepkorn M, Bothwell M: Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. J Am Acad Dermatol 1996, 35:725-731
40. Kanik AB, Yaar M, Bhawan J: p75 nerve growth factor receptor staining helps identify desmoplastic and neurotrophic melanoma. J Cutan Pathol 1996, 23:205-210
41. Barnhill RL: Tumors of melanocytes. Textbook of Dermatopathology. Edited by RL Barnhill. New York, McGraw-Hill, 1998, pp 537-591
42. Cunningham BA, Hemperly JJ, Murray BA, Prediger EA, Brackenbury R, Edelman GM: Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 1987, 236:799-806
43. Miettinen M, Cupo W: Neural cell adhesion molecule distribution in soft tissue tumors. Hum Pathol 1993, 24:62-66
44. Mechtersheimer G, Staudter M, Moller P: Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and their tumors. Cancer Res 1991, 51:1300-1307
45. Nguyen C, Mattei MG, Mattei JF, Santoni MJ, Goridis C, Jordan BR: Localization of the human NCAM gene to band q23 of chromosome 11: the third gene coding for a cell interaction molecule mapped to the distal portion of the long arm of chromosome 11. J Cell Biol 1986, 102:711-715
46. Curtis R, Stewart HJS, Hall SM, Wilkin GP, Mirsky R, Jessen KR: Gap-43 is expressed by nonmyelin-forming Schwann cells of the peripheral nervous system. J Cell Biol 1992, 116:1455-1464
47. Strittmatter SM, Valenzuela D, Kennedy TE, Neer EJ, Fishman MC: GO is a major growth cone protein subject to regulation by GAP-43. Nature 1990, 344:836-841
48. Oehrlein SA, Parker PJ, Herget T: Phosphorylation of GAP-43 (growth-associated protein of 43 kd) by conventional, novel, and atypical isotypes of the protein kinase C gene family: differences between oligopeptide and polypeptide phosphorylation. Biochem J 1996, 317:219-224
49. He Q, Dent EW, Meiri KF: Modulation of actin filament behavior by GAP-43 (neuromodulin) is dependent on the phosphorylation status of serine 41, the protein kinase C site. J Neurosci 1997, 17:3515-3524
50. Bosse F, Zoidl G, Wilms S, Gillen CP, Kuhn HG. Muller HW: Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelmation. J Neurosci Res 1994, 37:529-537
51. Suter U, Snipes GJ, Schoener-Scott R, Welcher AA Sangeeta P, Lupski JR, Murphy RA, Shooter EM, Patel Pl: Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 1994, 269:25795-25808
52. Kühn G, Lie A, Wilms S, Muller HW: Coexpression of PMP22 gene with MBP and PO during de novo myelination and nerve repair. Glia 1993. 8:256-264
53. Kosik KS, Orecchio LD, Bruns GA. Benowitz LI, MacDonald GP, Cox DR, Neve RL: GAP-43: its deduced amino acid sequence and chromosomal localization in mouse and human. Neuron 1988, 1:127-132
54. Skelton HG, Smith KJ, Laskin WB, McCarthy WF, Gagnier JM, Graham JH, Lupton GP: Desmoplastic malignant melanoma, J Am Acad Dermatol 1995, 32:717-725
55. Baer SC, Schultz D, Synnestvedt M, Elder DE: Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma. Cancer 1995, 76:2242-2247